{"id":"NCT00720798","sponsor":"Hoffmann-La Roche","briefTitle":"An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies","officialTitle":"Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in MRA Core Studies","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-09","primaryCompletion":"2013-04","completion":"2013-04","firstPosted":"2008-07-23","resultsPosted":"2014-09-30","lastUpdate":"2014-09-30"},"enrollment":2067,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Tocilizumab","otherNames":["RoActemra","Actemra"]},{"type":"DRUG","name":"Disease-modifying anti-rheumatic drugs","otherNames":[]},{"type":"DRUG","name":"Non-steroidal anti-inflammatory drugs","otherNames":[]},{"type":"DRUG","name":"Oral corticosteroids","otherNames":[]}],"arms":[{"label":"Tocilizumab","type":"EXPERIMENTAL"}],"summary":"This single-arm study evaluated the long-term efficacy and safety of tocilizumab in participants who had completed treatment in the tocilizumab core studies (NCT00106522 \\[Roche protocol WA18062\\], NCT00106574 \\[Roche protocol WA18063\\], and NCT00109408 \\[Roche protocol WA17824\\]) of adults with rheumatoid arthritis. Participants received tocilizumab alone or in combination with standard anti-rheumatic treatment.","primaryOutcome":{"measure":"Percentage of Participants With â‰¥ 1 Adverse Event","timeFrame":"Baseline to the end of the study (up to 7 years, 7 months)","effectByArm":[{"arm":"Tocilizumab","deltaMin":96.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":6},"locations":{"siteCount":295,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","China","Costa Rica","Czechia","Denmark","Finland","France","Germany","Hong Kong","Iceland","Israel","Italy","Lithuania","Mexico","Netherlands","Norway","Panama","Peru","Portugal","Puerto Rico","Russia","Serbia","Slovenia","South Africa","Spain","Sweden","Switzerland","Thailand","United Kingdom"]},"refs":{"pmids":["27909081"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":727,"n":2067},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Urinary tract infection","Hypertension","Bronchitis"]}}